Related references
Note: Only part of the references are listed.Colloidal stability and physicochemical characterization of bombesin conjugated biodegradable nanoparticles
Hitesh Kulhari et al.
COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS (2014)
Peptide conjugated polymeric nanoparticles as a carrier for targeted delivery of docetaxel
Hitesh Kulhari et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2014)
Bombesin Analogue-Mediated Delivery Preferentially Enhances the Cytotoxicity of a Mitochondria-Disrupting Peptide in Tumor Cells
Hao Yang et al.
PLOS ONE (2013)
Cytotoxicity and apoptotic signalling cascade induced by chelidonine-loaded PLGA nanoparticles in HepG2 cells in vitro and bioavailability of nano-chelidonine in mice in vivo
Avijit Paul et al.
TOXICOLOGY LETTERS (2013)
Proteomic Profiling of Androgen-independent Prostate Cancer Cell Lines Reveals a Role for Protein S during the Development of High Grade and Castration-resistant Prostate Cancer
Punit Saraon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Piceatannol inhibits migration and invasion of prostate cancer cells: possible mediation by decreased interleukin-6 signaling
Gyoo Taik Kwon et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2012)
Nanoparticle therapeutics for prostate cancer treatment
Vanna Sanna et al.
MATURITAS (2012)
Overcoming docetaxel resistance in prostate cancer: a perspective review
Clara Hwang
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2012)
A new era for castrate resistant prostate cancer: A treatment review and update
Mei Ka Fong et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2012)
Advances in Wound-Healing Assays for Probing Collective Cell Migration
Reza Riahi et al.
JALA (2012)
PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine
Martin A. Cheever et al.
CLINICAL CANCER RESEARCH (2011)
Synthesis, cellular uptake, apopotosis, cytotoxicity, cell cycle arrest, interaction with DNA and antioxidant activity of ruthenium(II) complexes
Hong-Liang Huang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): Preparation, pharmacokinetics, tissue distribution and antitumor activity
Lili Wang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Nanomedicinal strategies to treat multidrug-resistant tumors: current progress
Xiaowei Dong et al.
NANOMEDICINE (2010)
Multifunctional nanoparticles for prostate cancer therapy
Carolina Salvador-Morales et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2009)
Bcl-2 Modulation to Activate Apoptosis in Prostate Cancer
Kevin Bray et al.
MOLECULAR CANCER RESEARCH (2009)
Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats
Michelle Longmire et al.
NANOMEDICINE (2008)
International Union of Pharmacology. LXVIII. Mammalian Bombesin Receptors: Nomenclature, Distribution, Pharmacology, Signaling, and Functions in Normal and Disease States
R. T. Jensen et al.
PHARMACOLOGICAL REVIEWS (2008)
Drug Nanoparticles: Formulating Poorly Water-Soluble Compounds
Elaine M. Merisko-Liversidge et al.
TOXICOLOGIC PATHOLOGY (2008)
Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy
D. B. Cornelio et al.
ANNALS OF ONCOLOGY (2007)
The human PC346 xenograft and cell line panel: A model system for prostate cancer progression
RB Marques et al.
EUROPEAN UROLOGY (2006)
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
IF Tannock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Clinical pharmacokinetics of unbound docetaxel: Role of polysorbate 80 and serum proteins
WJ Loos et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
The mechanism of action of docetaxel (Taxotere®) in xenograft models is not limited to bcl-2 phosphorylation
LA Kraus et al.
INVESTIGATIONAL NEW DRUGS (2003)
Share Paper
